Hospira names Richard Davies as chief commercial officer

Brings 20 years’ experience to the role

Richard Davies

Hospira, a US provider of injectable drugs and infusion technologies based in Lake Forest, Illinois, has appointed Richard Davies as senior vice president and chief commercial officer.

In this role, which he starts tomorrow (2 February), Davies will be responsible for developing and executing Hospira’s global commercial strategies and delivering revenue growth across the company’s product portfolio.

Davies brings more than 20 years of diverse strategic and operational experience to Hospira gained through a variety of commercial management positions and across a range of products and technologies.

Most recently, he was vice president and general manager, Japan, Asia Pacific and Latin America, for Amgen, where he was responsible for establishing Amgen's business in the region as well as supporting its strategy development for emerging markets overall. During his eight years at Amgen, he led the company’s commercial organisations in Central/Eastern Europe and Australia, and also served as vice president of US sales for the immunology franchise.

Prior to joining Amgen, Davies spent 13 years at Eli Lilly in roles of increasing commercial responsibility, including general country management.

Companies